Intellectual Property (IP) Challenges during Uncertain Times - McDermott

Intellectual Property (IP) Challenges during Uncertain Times

Overview



McDermott Will & Emery and Marcum LLP are committed to sharing the best information available concerning the coronavirus (COVID-19) pandemic to our clients and colleagues during this time. The evolving ecosystem in the life sciences and biotechnology sector creates new challenges for companies throughout all stages of their intellectual property (IP) and product lifecycle—and with those new challenges come new opportunities.

Many life sciences companies are working faster than ever to discover new treatments and/or vaccines for COVID-19. This race to innovate has increased collaborations between competitors and may create interesting challenges and opportunities with respect to IP rights and obligations. This joint session will feature a panel of subject matter experts as they discuss managing IP issues in these uncertain times from a legal and industry perspective.

TOPICS INCLUDE:

  • Challenges/Opportunities in Collaboration
  • Challenges/Opportunities in Patent Enforcement and Defense
  • Impacts on Damages and Injunction

This Continuing Legal Education (CLE) training session counts for 1.0 credit hour in Connecticut and New York. Appropriate for newly admitted and experienced attorneys (transitional/non-transitional).

Dig Deeper

Paris, France / McDermott Event / April 2, 2025

European Health & Life Sciences Symposium 2025

Atlanta, GA / Speaking Engagements / May 18-22, 2024

INTA 2024 Annual Meeting

Palo Alto / Speaking Engagements / May 22, 2024

The AI Strategy Summit: IP, Data and Compliance

Boston, MA / Speaking Engagements / May 8-9, 2024

LSPN North America – Spring 2024